Xavier Paoli of Pharnext
joined us for World Orphan Drug Congress USA 2015 to present about '
Pharnext Pleotherapy Approach in Orphan Neuropathies'
Download the presentation now to learn more about:
-
R&D process
-
R&D paradigm: pleotherapy
-
CMT1A: Slow progressive peripheral neuropathy
-
PXT-3003 for the treatment of CMT1A
...and
much
more!
Get your copy here!
To find out more about how
PXT-3003 can aid in the treatment of CMT1A
, join us at
World Orphan Drug Congress USA 2016 April 20-22
in Washington, DC.